asa glp 1 recommendations The 2023 position on GLP-1 receptor agonists has been overturned by three 2025 consensus statements. Continue the drug. Change the fast. ANZCA/ADS/GESA/NACOS, the Association of Anaesthetists/RCoA, and SPAQI/AACE now converge on asa guidelines for glp-1 agonists

Selecting the right C-rating means matching the battery to your systems actual current demands

PlexusDx occupies a middle ground: compounded formulations at lower cost, paired with optional genetic testing to enrich provider decision-making

For someone with Hashimotos or hypothyroidism, adding these side effects on top of things like fatigue and hair loss can be completely debilitating

Smoking, alcohol, and junk food reduce its benefits

If you are experiencing consistent side effects at steady state (not just during the transition), that tells you the dose itself is probably too high for your tolerance, not that you are going through a temporary adjustment period

Hair from elsewhere on the body be it your beard, arms and legs, or torso is an excellent source to use when in search of a wide range of options for transplant needs